As of 2026-06-16, the Intrinsic Value of Vireo Health International Inc (VREO.CN) is 3.50 CAD. This VREO.CN valuation is based on the model Discounted Cash Flows (Growth Exit 10Y). With the current market price of 16.77 CAD, the upside of Vireo Health International Inc is -79.20%.
The range of the Intrinsic Value is (0.01) - 11.24 CAD
Based on its market price of 16.77 CAD and our intrinsic valuation, Vireo Health International Inc (VREO.CN) is overvalued by 79.20%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (4.86) - 0.72 | (3.13) | -118.7% |
| DCF (Growth 10y) | (0.01) - 11.24 | 3.50 | -79.2% |
| DCF (EBITDA 5y) | 8.59 - 22.43 | 14.55 | -13.3% |
| DCF (EBITDA 10y) | 14.19 - 35.23 | 22.96 | 36.9% |
| Fair Value | -12.41 - -12.41 | -12.41 | -173.98% |
| EV/EBITDA | 7.80 - 23.57 | 14.27 | -14.9% |
| EPV | (6.99) - (6.55) | (6.77) | -140.4% |
| DDM - Stable | (38.70) - (564.52) | (301.61) | -1898.5% |
| DDM - Multi | (7.07) - (80.70) | (13.04) | -177.7% |
| Market Cap (mil) | 774.40 |
| Beta | 0.26 |
| Outstanding shares (mil) | 46.18 |
| Enterprise Value (mil) | 1,167.94 |
| Market risk premium | 5.10% |
| Cost of Equity | 6.44% |
| Cost of Debt | 22.38% |
| WACC | 9.85% |